Replies to post #130284 on PharmaCyte Biotech Inc (PMCB)

[DragonBear]

we are there finally-as in nowhere.

once ind is submitted,a new way to fight solid tumors,pc

Best case scenario... It lowers the metastatic tumor load for 2-3 months. Might initially shrink a 2nd line PC patient's tumor by 20%. Due to the lower tumor load the patient feels better for 2-3 months. Then they die.

pc is just about the worst and is the best place to start,a 94% deathrate,my uncle being 1,pc patients need something thats for sure

Sometime in the next 1-2 yrs there will be "something". A treatment that will increase the successful removal of the primary tumor, not by 100%, but by 500% in 1st line patients. Another 2 yrs beyond that there will be immunotherapies used to try to clean up the metastatic disease after surgery. Then one will have a viable treatment for 1st line patients "fur sure". Where most will never become 2nd line patients.

and is the best place to start,a 94% deathrate,my uncle being 1

The Kenny Wonder Treatment is the worse place to start, or even end. It will have no effect on that 94%, using a drug which has failed in past 2nd line PC CTs. Neither has there ever been a control arm run showing the presence of CIABs does anything. Oncologists aren't stoopid. They won't be sending to patients to participate in any Phase 1 CT for the Kenny Wonder Treatment. If it ever gets that far, the enrollment numbers will reflect the lack of interest in an unproven chemo treatment from 20 yrs ago.